サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1641785

大腿骨管ブラシの世界市場：用途別、用途別、エンドユーザー別 - 機会分析と産業予測、2024年～2033年

Femoral Canal Brush Market By Usage , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 240 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
大腿骨管ブラシの世界市場：用途別、用途別、エンドユーザー別 - 機会分析と産業予測、2024年～2033年
出版日: 2024年11月01日
発行: Allied Market Research
ページ情報: 英文 240 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

大腿骨管ブラシ市場は、2023年に3億5,010万米ドルとなり、2024年から2033年にかけてCAGR3.3％で成長し、2033年までには4億8,490万米ドルに達すると予測されています。

Femoral Canal Brush Market-IMG1

大腿骨管ブラシは、整形外科手術、特に人工関節置換手術の際に使用される特殊な手術器具です。このブラシは、大腿骨（太ももの骨）内の空洞である大腿管を洗浄し、準備するように設計されており、緩んだ骨の破片、脂肪、その他の軟部組織の残留物を除去します。この準備により、補綴コンポーネントの適切なセメンテーションと固定が保証され、長期的な安定性が促進され、インプラントのゆるみなどの合併症のリスクが軽減されます。

世界の大腿骨管ブラシ市場は、変形性関節症、関節リウマチ、外傷関連関節損傷などの関節障害の有病率の憂慮すべき上昇や、世界の整形外科手術件数の増加などの要因により、力強い成長を目の当たりにしています。世界保健機関（WHO）が発表した2022年の調査によると、2019年には世界で約5億2,800万人が変形性関節症に苦しんでいます。これは、大腿骨管ブラシのような手術ツールの緊急の必要性を強調しています。さらに、高齢者人口の急増は世界市場の主要な推進力として機能します。これは、世界の高齢化人口の急増に伴い、人工股関節置換術や人工膝関節置換術の需要が増加していることに起因しています。世界保健機関（WHO）が発表した2024年の調査では、高齢者の数が2020年の10億人から、2030年までには14億人に増加することが明らかになりました。さらに、80歳以上の高齢者数は2050年までに4億2,600万人に達すると推定されています。さらに、インド、ブラジル、中国などの新興経済諸国における医療インフラの急速な開拓により、整形外科手術へのアクセスが増加し、大腿骨管ブラシ市場の成長を支えています。術後感染症は、整形外科手術における重大な懸念事項であり続けています。大腿骨管ブラシは、清潔な手術部位を確保することで感染リスクを低減する上で重要な役割を果たしており、それによって需要がさらに高まっています。しかし、大腿骨管ブラシやその他の手術器具の高価格は、特に新興市場やヘルスケア予算が限られている地域では障壁となる可能性があります。加えて、大腿骨管ブラシを必要としない非侵襲的または低侵襲的な外科手術の増加は、その需要に影響を与える可能性があるため、市場の成長を妨げる可能性があります。これとは逆に、生体適合性や耐久性に優れた毛などの材料や設計の革新により、大腿骨管ブラシの効率が向上しています。このため、整形外科手術での採用が促進され、予測期間中の世界市場拡大に有益な機会を提供すると期待されています。

大腿骨管ブラシの世界市場規模は、用法、用途、エンドユーザー、地域に区分されます。用法別では、市場は洗浄とデブライドに二分されます。用途別では、骨セメント、人工股関節、人工関節、その他に分類されます。エンドユーザー別では、病院、外来手術センター、その他に分けられます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカで分析されています。

主要な調査結果

用法別では、洗浄分野が2024年から2033年にかけて市場を独占すると予測されます。

用途別では、骨セメント分野が予測期間中に最も高い成長率を示すと予測されています。

エンドユーザー別では、病院セグメントが今後数年間で大腿骨管ブラシ市場をリードすると予測されています。

地域別では、北米が予測期間を通じて大腿骨管ブラシの最も有利な市場として浮上する可能性が高いです。

本レポートのカスタマイズが可能です。（追加費用とスケジュールがあります。）

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要企業の詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要な調査結果
    • 主要な投資機会
    • 主要な成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 大腿骨管ブラシ市場：用法別

  • 市場概要
  • 洗浄
  • デブライド

第5章 大腿骨管ブラシ市場：用途別

  • 市場概要
  • 骨セメント
  • 股関節置換術
  • 関節置換術
  • その他

第6章 大腿骨管ブラシ市場：エンドユーザー別

  • 市場概要
  • 病院
  • 外来手術センター
  • その他

第7章 大腿骨管ブラシ市場：地域別

  • 市場概要
  • 北米
    • 主要な市場動向と機会
    • 米国の大腿骨管ブラシ市場
    • カナダの大腿骨管ブラシ市場
    • メキシコの大腿骨管ブラシ市場
  • 欧州
    • 主要市場動向と機会
    • ドイツの大腿骨管ブラシ市場
    • フランス大腿骨管ブラシ市場
    • 英国の大腿骨管ブラシ市場
    • イタリアの大腿骨管ブラシ市場
    • スペインの大腿骨管ブラシ市場
    • その他欧州の大腿骨管ブラシ市場
  • アジア太平洋
    • 主要な市場動向と機会
    • 日本の大腿骨管ブラシ市場
    • 中国の大腿骨管ブラシ市場
    • インドの大腿骨管ブラシ市場
    • オーストラリアの大腿骨管ブラシ市場
    • 韓国の大腿骨管ブラシ市場
    • その他アジア太平洋の大腿骨管ブラシ市場
  • ラテンアメリカ、中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの大腿骨管ブラシ市場
    • サウジアラビア大腿骨管ブラシ市場
    • 南アフリカの大腿骨管ブラシ市場
    • その他のラテンアメリカ、中東・アフリカの大腿骨管ブラシ市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2023年

第9章 企業プロファイル

  • Stryker Corporation
  • B. Braun SE
  • Becton, Dickinson And Company
  • Advanced Medical Systems Limited
  • McKesson Medical-Surgical Inc.
  • Judd Medical Limited
  • Zimmer Biomet
  • Smith And Nephew
  • Tecres S.p.A.
  • Edwards Lifesciences Corporation
目次
Product Code: A324002

The femoral canal brush market was valued at $350.1 million in 2023, and is projected to reach $484.9 million by 2033, growing at a CAGR of 3.3% from 2024 to 2033.

Femoral Canal Brush Market - IMG1

A femoral canal brush is a specialized surgical tool used in orthopedic procedures, particularly during joint replacement surgeries. It is designed to clean and prepare the femoral canal-the hollow space within the femur (thigh bone)-by removing loose bone debris, fat, and other soft tissue residues. This preparation ensures proper cementing and fixation of the prosthetic components, promoting long-term stability and reducing the risk of complications like implant loosening.

The global femoral canal brush market is witnessing robust growth due to factors such as alarming rise in prevalence of joint disorders such as osteoarthritis, rheumatoid arthritis, and trauma-related joint injuries and increase in number of orthopedic surgeries worldwide. As per a 2022 study published by the World Health Organization, approximately 528 million individuals worldwide were suffering from osteoarthritis in 2019. This highlights the urgent need for surgical tools like femoral canal brushes. In addition, surge in geriatric population acts as a key driving force of the global market. This is attributed to the fact that with the global aging population growing rapidly, the demand for hip and knee replacements is on the rise. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. Furthermore, rapid development of healthcare infrastructure in emerging economies, such as India, Brazil, and China, has increased access to orthopedic surgeries, supporting the growth of the femoral canal brush market. Post-operative infections remain a critical concern in orthopedic procedures. Femoral canal brushes play a key role in reducing the risk of infections by ensuring a clean surgical site, thereby further driving their demand. However, high cost of femoral canal brushes and other surgical instruments can be a barrier, particularly in emerging markets and regions with limited healthcare budgets. In addition, rise of non-invasive or minimally invasive surgical procedures, which might not require femoral canal brushes, could impact their demand, thus hampering the market growth. On the contrary, innovations in materials and design, such as biocompatible and durable bristles, have enhanced the efficiency of femoral canal brushes. This has driven their adoption in orthopedic procedures, which is expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The global femoral canal brush market size is segmented into usage, application, end user, and region. On the basis of the usage, the market is bifurcated into cleaning and debride. By application, it is classified into bone cement, hip replacement, joint replacement, and others. Depending on end user, it is divided into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By usage, the cleaning segment is expected to dominate the market from 2024 to 2033.

On the basis of application, the bone cement segment is anticipated to exhibit the highest growth rate during the forecast period.

Depending on end user, the hospitals segment is projected to lead the femoral canal brush market in the upcoming years.

Region wise, North America is likely to emerge as the most lucrative market for femoral canal brushes throughout the forecast period.

Competition Analysis

The major players operating in the global femoral canal brush market include Stryker Corporation, B. Braun SE, Becton, Dickinson and Company , Advanced Medical Systems Limited, McKesson Medical-Surgical Inc., Judd Medical Limited , Zimmer Biomet, Smith & Nephew, Tecres S.p.A., and Edwards Lifesciences Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Usage

  • Cleaning
  • Debride

By Application

  • Bone Cement
  • Hip Replacement
  • Joint Replacement
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Stryker Corporation
    • B. Braun SE
    • Becton, Dickinson and Company
    • Advanced Medical Systems Limited
    • McKesson Medical-Surgical Inc.
    • Judd Medical Limited
    • Zimmer Biomet
    • Smith & Nephew
    • Tecres S.p.A.
    • Edwards Lifesciences Corporation

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: FEMORAL CANAL BRUSH MARKET, BY USAGE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Usage
  • 4.2. Cleaning
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Debride
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: FEMORAL CANAL BRUSH MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Bone Cement
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Hip Replacement
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Joint Replacement
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: FEMORAL CANAL BRUSH MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: FEMORAL CANAL BRUSH MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Usage
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Femoral Canal Brush Market
      • 7.2.6.1. Market Size and Forecast, By Usage
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Femoral Canal Brush Market
      • 7.2.7.1. Market Size and Forecast, By Usage
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Femoral Canal Brush Market
      • 7.2.8.1. Market Size and Forecast, By Usage
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Usage
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Femoral Canal Brush Market
      • 7.3.6.1. Market Size and Forecast, By Usage
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Femoral Canal Brush Market
      • 7.3.7.1. Market Size and Forecast, By Usage
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Femoral Canal Brush Market
      • 7.3.8.1. Market Size and Forecast, By Usage
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Femoral Canal Brush Market
      • 7.3.9.1. Market Size and Forecast, By Usage
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Femoral Canal Brush Market
      • 7.3.10.1. Market Size and Forecast, By Usage
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest Of Europe Femoral Canal Brush Market
      • 7.3.11.1. Market Size and Forecast, By Usage
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Usage
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Femoral Canal Brush Market
      • 7.4.6.1. Market Size and Forecast, By Usage
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Femoral Canal Brush Market
      • 7.4.7.1. Market Size and Forecast, By Usage
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Femoral Canal Brush Market
      • 7.4.8.1. Market Size and Forecast, By Usage
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Femoral Canal Brush Market
      • 7.4.9.1. Market Size and Forecast, By Usage
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Femoral Canal Brush Market
      • 7.4.10.1. Market Size and Forecast, By Usage
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Femoral Canal Brush Market
      • 7.4.11.1. Market Size and Forecast, By Usage
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Usage
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Femoral Canal Brush Market
      • 7.5.6.1. Market Size and Forecast, By Usage
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Femoral Canal Brush Market
      • 7.5.7.1. Market Size and Forecast, By Usage
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Femoral Canal Brush Market
      • 7.5.8.1. Market Size and Forecast, By Usage
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Femoral Canal Brush Market
      • 7.5.9.1. Market Size and Forecast, By Usage
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping Of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Stryker Corporation
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. B. Braun SE
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Becton, Dickinson And Company
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Advanced Medical Systems Limited
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. McKesson Medical-Surgical Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Judd Medical Limited
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Zimmer Biomet
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Smith And Nephew
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Tecres S.p.A.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Edwards Lifesciences Corporation
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments